- Zacks•6 hours ago
Third quarter earnings season is in full flow with several companies like Lilly (LLY), Merck, Bristol-Myers, Novartis and others reporting results this week.
- Business Wire•8 hours agoNew Data Shows Frequent ICU Admissions from Severe RSV Disease among Preterm Infants in the First Three Months of Life
AstraZeneca today announced data from the second season of its SENTINEL1 study, the largest study ever to examine laboratory-confirmed respiratory syncytial virus hospitalizations among US preterm infants 29-35 weeks gestational age who were <12 months of age at the time of their RSVH admission.1,2 Infants enrolled did not receive immunoprophylaxis within 35 days before the onset of RSV disease ...
- Reuters•19 hours ago
The following are the top stories in the Financial Times. Reuters has not verified these stories and does not vouch for their accuracy. Headlines * Special visa schemes for regions rejected http://on.ft.com/2eVztAW ...
AstraZeneca PLC (AZN)
NYSE - NYSE Real Time Price. Currency in USD
|Bid||28.59 x 3200|
|Ask||28.60 x 2500|
|Day's Range||28.08 - 28.76|
|52wk Range||26.97 - 35.04|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||32.66|
|Avg Vol (3m)||5,434,495|
|Dividend & Yield||0.90 (3.04%)|